Animal studies indicate that the loss of GLUT9 function in mice causes hyperuricemia, hyperuricosuria, and early onset nephropathy [21,74]; in contrast, the dysfunction of GLUT9 in humans is associated with hypouricemia. Here, SLC2A9 is linked to kidney disorder.